StockNews.com Initiates Coverage on BIOLASE (NASDAQ:BIOL)

StockNews.com started coverage on shares of BIOLASE (NASDAQ:BIOL – Get Rating) in a research note issued on Wednesday. The brokerage set a “sell” rating on the medical technology company’s stock. Separately, Lake Street Capital reissued a “buy” rating on shares of BIOLASE in a research report on Friday, January 20th. BIOLASE Stock Performance Shares of […]

Related Keywords

,Essex Investment Management Co ,Citadel Advisors ,Biolase Inc ,Company Profile ,Renaissance Technologies ,Capital Wealth Alliance ,Get Rating ,Lake Street Capital ,Wealth Alliance ,Street Corp ,Essex Investment Management ,Investment Management ,Biolase ,Nasdaq Biol ,Fbiol ,Medical ,Initiated Coverage ,Stocknews Com ,